Your browser doesn't support javascript.
loading
Oral anticoagulant use after catheter ablation for atrial fibrillation based on thrombo-embolic risk: future studies will be needed for bleeding high-risk group.
Kanaoka, Koshiro; Iwanaga, Yoshitaka.
Affiliation
  • Kanaoka K; Department of Medical and Health Information Management, National Cerebral and Cardiovascular Center, Kishibe-Shimmachi 6-1, Suita, Osaka 564-8565, Japan.
  • Iwanaga Y; Department of Medical and Health Information Management, National Cerebral and Cardiovascular Center, Kishibe-Shimmachi 6-1, Suita, Osaka 564-8565, Japan.
Eur Heart J ; 45(32): 2997-2998, 2024 Aug 21.
Article in En | MEDLINE | ID: mdl-38953778
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Thromboembolism / Catheter Ablation / Hemorrhage / Anticoagulants Limits: Humans Language: En Journal: Eur Heart J Year: 2024 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Thromboembolism / Catheter Ablation / Hemorrhage / Anticoagulants Limits: Humans Language: En Journal: Eur Heart J Year: 2024 Document type: Article Affiliation country: Country of publication: